Global B2B Pharmaceutical Sourcing · Dossier Licensing · Named-Patient Access
💬 WhatsApp · Sign in · Register
Procarbazine bulk supplier for pharma manufacturers

Procarbazine 50 mg Suppliers & Bulk Manufacturers

Available Forms: Capsules

Available Strengths: 50 mg

Reference Brands: Matulane(US), Procarbazine(EU)

Category: Oncology Cancer Care

Procarbazine Capsules 50 mg are used in the treatment of Hodgkin lymphoma, non-Hodgkin lymphoma, and certain brain tumors. As an alkylating chemotherapy agent, Procarbazine interferes with DNA replication, preventing cancer cell growth. Approved in both the U.S. and EU, it is a key part of combination chemotherapy regimens for oncology B2B distribution.

Get Enquiry / Request Bulk Quote

Quick Response Guaranteed | Verified Suppliers

Product Description: Procarbazine Capsules 50 mg are an essential oral chemotherapy drug used in the treatment of Hodgkin lymphoma, non-Hodgkin lymphoma, and certain brain tumors. As an alkylating agent, it interferes with DNA replication, preventing cancer cell growth. Approved in both the U.S. and EU, Procarbazine is typically used in combination with other chemotherapy agents. Available in 50 mg capsules, it plays a crucial role in oncology B2B distribution, supporting hospitals and oncology centers in treating hematologic and solid tumors. Its use in combination therapies provides a comprehensive approach to cancer treatment.

Procarbazine — third party manufacturing & bulk supply

Procarbazine 50 mg is available through PharmaTradz for wholesale and bulk supply as well as on a third party (contract) manufacturing basis. Buyers sourcing this product generally take one of three routes:

Wholesale / bulk supply Stock or scheduled supply from an existing manufacturer. The fastest route where the product is already registered in your market.
Third party manufacturing Manufactured to your specification and packed under your own brand and label — suits distributors and brand owners building a portfolio in their market.
Dossier licensing Where a CTD, EU-CTD or ACTD dossier exists it can often be licensed for filing in your name, compressing market entry from years to months.

Indicative minimum order quantity

Procarbazine is supplied as Capsules — an oral solid dosage form, so the indicative MOQ is 200,000 units. Actual MOQ is confirmed by the allocated manufacturer against your pack presentation and destination market. See full supply terms for dossier formats, market availability and shelf life.

Manufacturers of Procarbazine listed on PharmaTradz hold site-level approvals across WHO-GMP, EU-GMP, USFDA, ANVISA and TGA, verified at onboarding.

Request a quote for Procarbazine →
Back to Listing

Frequently Asked Questions

Procarbazine is listed as Capsules in 50 mg. Further strengths and pack presentations are confirmed with the manufacturer at RFQ stage.

Procarbazine is referenced against Matulane(US), Procarbazine(EU). Reference brands are shown for identification only and remain the property of their respective trademark owners.

Related Products

Pemetrexed Injection

Strength:
100 mg/4 mL vial, 500 mg/20 mL vial

Form: Injection

Reference Brands: Pemfexy (USA)

View Details
Progestin Injection

Strength:
50 mg/mL, 100 mg/mL

Form: Injection

Reference Brands: Depo-subQ Provera 104(US)

View Details
Rasburicase Injection

Strength:
7.5 mg/15 mL vial

Form: IV infusion

Reference Brands: Elitek(US)

View Details
Palonosetron 0.25 Mg Injection

Strength:
0.25 mg/5 mL vial

Form: Injection

Reference Brands: Posfrea (USA)

View Details
Bexarotene

Strength:
75 mg

Form: Capsules

Reference Brands: Targretin (USA/EU)

View Details
Encorafenib

Strength:
50mg, 75 mg

Form: Capsules

Reference Brands: Braftovi (USA/EU)

View Details
Bleomycin

Strength:
15,000 IU

Form: Injection

Reference Brands: Generic formulations marketed under different names

View Details
Blinatumomab

Strength:
35mcg

Form: Injection

Reference Brands: Blincyto (USA/EU)

View Details
Enquire Now

Quick Response Guaranteed | Verified Suppliers

Subscribe to Our Newsletter

Stay updated on pharma trends and sourcing opportunities.

Please enter the correct answer.
This website uses cookies to ensure you get the best experience. By using our site, you agree to our Privacy Policy.